+467.0%
MRNA vs NVMI
+32.8%
+434.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NVMI | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +1.6% | +3.8% | +5.1% |
| 7D | -1.1% | -0.1% | -1.0% | -1.1% |
| 30D | +126.1% | -8.4% | +134.5% | +130.1% |
| 3M | +190.0% | -33.6% | +223.6% | +213.5% |
| 6M | +157.2% | -14.7% | +171.9% | +149.1% |
| YTD | +388.2% | +13.2% | +375.0% | +326.2% |
| 1Y | +467.0% | +29.0% | +438.0% | +358.6% |
| All | +467.0% | +32.8% | +434.3% | +358.6% |
Cumulative growth
Daily Returns
Daily percentage return beside NVMI.
Daily Out/Under-Performance
Portfolio return minus NVMI return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NVMI return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NVMI wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling